Moving in the Right Direction: Cocrystals and the FDA

Read More

Using Solid Form Patents to Protect Pharmaceutical Products — Part I

Read More

Using Solid Form Patents to Protect Pharmaceutical Products — Part II

Read More


Strafford Webinar:
Drug Substance Patents
July 10, 2019
Eyal Barash of Barash Law LLC and Dr. Steef Boerrighter of AMRI will be presenting a 90-minute CLE Webinar with interactive Q&A. This webinar is a follow-up to the presentation on April 25th on solid-form patents and is being scheduled due to high demand.

Please send any questions you want answered during the program to We will make every effort to cover those issues in the presentation.
Read More
PPXRD Symposium on IP Rights and Counterfeit Drugs
Paul Scherrer institute
may 9-12, 2019
Eyal Barash will be speaking at the 16th Pharmaceutical Powder X-Ray Diffraction Symposium on Intellectual Property Rights and Counterfeit Drugs. This forum featuring various speakers will include sharing of knowledge and ideas on the combined fields of XRD and pharmaceutical sciences. The symposium is followed by a workshop with useful applications of X-Ray analysis in the study of pharmaceutical materials. Deadline for registration to attend is April 15th.
Read More


What is a solid form?

A solid form is the solid representation of a chemical compound.  Examples include polymorphs, salts, solvates, hydrates, cocrystals, and amorphous solids.

Why patent solid forms?

Solid forms are compositions of matter and Orange-Book listable as drug substance.  When the science is right, patenting follows.

How do you patent a solid form?

The same rules apply to solid forms as to any other inventions.  Careful attention should be paid to the kinds and quality of data used in solid form patents.


pharmaceutical patents

Orange-Book Listable Patents Add Value


Intellectual Property as Deal Currency

ip strategy and execution

A Strategy Requires a Realistic Plan


Legal Functionality as a Business Driver